Xiaofang Xiong

机构：Texas A&M Health Science Center, Texas A&M University · ORCID：0000-0001-8276-4415

发表论文 40 篇 · 总被引 658 次 · h-index 13

代表论文

• Metabolic Reprogramming and Reactive Oxygen Species in T Cell Immunity (2021 · Frontiers in Immunology · 被引 134)
• Insights Into the Pathologic Roles and Regulation of Eukaryotic Elongation Factor-2 Kinase (2021 · Frontiers in Molecular Biosciences · 被引 32)
• Autophagy in T‐cell differentiation, survival and memory (2020 · Immunology and Cell Biology · 被引 31)
• Tumorous expression of NAC1 restrains antitumor immunity through the LDHA-mediated immune evasion (2022 · Journal for ImmunoTherapy of Cancer · 被引 27)
• Control of CD4+ T cells to restrain inflammatory diseases via eukaryotic elongation factor 2 kinase (2023 · Signal Transduction and Targeted Therapy · 被引 25)
• Development of CAR-T Cell Persistence in Adoptive Immunotherapy of Solid Tumors (2021 · Frontiers in Oncology · 被引 25)